Arphra/Issuer/FREDUN.BO

FREDUN.BO

Fredun Pharmaceuticals Limited

HealthcareMedical - PharmaceuticalsININRCountry macro →

$2,375.70

Jun 02, 2026

AI Brief

Revenue · FY

$6.39B

Net income

$326.21M

FY 2026

EPS · diluted

$61.23

EBITDA

$945.41M

Explain this page

Arphra AIPlain-English read on Fredun Pharmaceuticals Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

0 txns

Net flow

+$0

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$2375.70

Change

+53.10%

Period high

$2552.75

Period low

$1534.10

Period start

$1551.702026-02-01

Through 2026-06-02

Peers

No peer list available for FREDUN.BO.

Sector & industry today

Live

Sectors

Industrials
+1.70%
Healthcare
+1.22%
Real Estate
+1.22%
Energy
+1.06%
Financial Services
+0.58%
Basic Materials
+0.55%
Consumer Defensive
+0.47%
Utilities
+0.46%
Consumer Cyclical
+0.45%
Communication Services
-1.49%
Technology
-1.63%

Top industries (issuer's industry highlighted)

Broadcasting
-4.83%
Investment - Banking & Investment Services
-4.58%
Auto - Recreational Vehicles
+3.94%
Software - Application
-3.85%
Electronic Gaming & Multimedia
-3.62%
Software - Infrastructure
-3.57%
Solar
-3.25%
Information Technology Services
-3.12%
Rental & Leasing Services
+3.04%
Agricultural - Machinery
+2.97%
Consulting Services
-2.84%
Agricultural Farm Products
+2.74%

Fair value

Football field →

Weighted blend

$1,345.31

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Total assets

$6.42B

Total debt

$2.22B

Cash & equiv

$649.81M

Operating CF

$777.67M

Free cash flow

$41.76M

Buybacks

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for FREDUN.BO.

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$6.39B	$862.94M	$326.21M	$61.23	+5.10%